COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details. editor@innovativepublication.com, rakesh.its@gmail.com, Mob. 8826373757, 8826859373, 9910947804

Introduction and Objectives: Escherichia coli and Klebsiella pneumoniae are major uropathogenic isolates producing Extended spectrum beta lactamases (ESBL) which confer high resistance to common antibiotics. This study was done to know the antibiogram pattern of ESBL producing isolates from urine samples. Materials andMethods:Culture and Antibiotic susceptibility tests (AST) were done from midstream urine samples (MSU) collected from patients. AST was done by Kirby-Bauer disc diffusion method and the isolates resistant to ceftriaxone and cefotaxime were subjected to phenotypic double disc diffusion test as per CLSI guidelines using cefotaxime (30?g) disc alone and cefotaxime plus clavulanic acid (30/10?g) combined disc for confirmation of ESBL production. Results: Out of 726 urine samples, 172 showed significant growth. Among 172 isolates, klebsiella species(10.4%).Total ESBL producers among these isolates were 68 (39.5%). Of which 63(92.6%) E.coli and 5 (7%) Klebsiella spp. These ESBL producing E.coli showed maximum resistance to Ampicillin and sensitivity to Nitrofurantoin. Similarly Klebsiella spp. showed maximum resistance to Ampicillin and sensitivity to Amikacin. These ESBL producing E.coli & Klebsiella spp. were also minimally resistant to Meropenem, about 14% and 20% respectively.most predominant isolate was Escherichia coli (81%) and then Conclusion: ESBL producing E.coli was high among uropathogens and most of them were highly resistant. So antibiotic sensitivity testing should be routinely done in order to prevent antibiotic resistance and treatment failure. Treatment should be followed according to the local antibiogram to specific ESBL producing isolates.